Table 7.

Univariate analysis: Transplant outcomes for patients on hemodialysis (HD) at time of allogeneic HCT (N=46)

Outcomes	N Eval	Prob (95% CI)
Overall survival	46
1-year		20 (10-32)%
3-year		17 (8-29)%
Relapse (malignant disease only)	36
1-year		22 (10-38)%
3-year		26 (12-43)%
NRM (malignant disease only)	36
1-year		67 (50-81)%
3-year		67 (50-81)%
Disease-free survival (malignant disease only)	36
1-year		11 (3-23)%
3-year		7 (1-19)%
Acute GVHD grade II-IV	46
1-year		20 (10-33)%
Acute GVHD grade III-IV	46
1-year		14 (5-25)%
Chronic GVHD	46
1-year		12 (4-25)%
TMA	46
1-year		4 (0-12)%
VOD	44
1-year		7 (1-16)%
IPS	46
1-year		4 (0-12)%